Leukemic Presentation of ALK-positive Anaplastic Large Cell Lymphoma with a Novel Partner, Poly(a) Binding Protein Cytoplasmic 1 (PABPC1), Responding to Single-Agent Crizotinib.
Haematologica（2019）
Key words
ALK Inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined